Sevag Chalian v. CVS Pharmacy, Inc

District Court, C.D. California·Decided July 16, 2021·No. 2:16-cv-08979·Unknown

Opinion

1 JS-6

7 UNITED STATES DISTRICT COURT 8 FOR THE CENTRAL DISTRICT OF CALIFORNIA 9 10 SEVAG CHALIAN, et al., CASE NO.: 2:16-cv-08979-AB-AGR Plaintiffs, 11 Related Case No.: 2:20-cv-02401-AB- 12 v. AGR CVS PHARMACY, INC., a Rhode 13 Island corporation; CVS RX Assigned to Hon. André Birotte Jr. 14 SERVICES, INC., a New York corporation; GARFIELD BEACH [PROPOSED] ORDER AND 15 CVS, LLC, a California limited JUDGMENT GRANTING (1) liability company; and DOES 1 thru MOTION FOR ORDER 16 100, inclusive, GRANTING FINAL APPROVAL OF CLASS ACTION 17 Defendants. SETTLEMENT AND (2) MOTION FOR AWARD OF ATTORNEYS’ REPRESENTATIVE 19 INCENTIVE/SERVICE AWARDS

20 DATE: December 4, 2020 TIME: 10:00 am 21 PLACE: Crtm. 7B, 350 West First St., Los Angeles, CA 22

23 Complaint Filed: July 20, 2016 Action Removed: December 5, 2016 24

27 1 This matter came before the Court for hearing on December 4, 2020 for final 2 approval of the Settlement. The parties have submitted their Global Settlement 3 Agreement (“Settlement Agreement”) evidencing their proposed settlement (the 4 “Settlement”), which this Court preliminarily approved in its August 5, 2020 Order. 5 In accordance with the preliminary approval order, Settlement Class Members have 6 been given notice of the terms of the Settlement and the opportunity to object to it. 7 In addition, pursuant to the Class Action Fairness Act of 2005, 28 U.S.C. § 1715 8 (“CAFA”), the Attorney Generals of each sta te where Settlement Class members 9 resided at the time notice was issued have been given notice of the Settlement. 10 Notice of this Settlement was also provided to the Labor and Workforce 11 Development Agency. 12 The Court has received and considered the Global Settlement Agreement dated 13 March 2, 2020, as amended by the First Amendment to Global Settlement 14 Agreement dated November 6, 2020 and the Second Amendment to Global 15 Settlement Agreement dated March 19, 2021 which the Court hereby approves (all 16 attached hereto as Exhibit A), the supporting papers filed by the parties, and the 17 evidence and argument received by the Court at the final approval hearing on 18 December 4, 2020. For the reasons explained at length in the Court’s concurrently- 19 issued ORDER GRANTING PLAINTIFFS’ MOTION FOR FINAL APPROVAL 21 OBJECTIONS, the Court GRANTS final approval of the Settlement, and HEREBY 22 ORDERS and MAKES DETERMINATIONS as follows: 23 24 1. The Motion for Order Granting Final Approval of Class Action 25 Settlement and Motion for Award of Attorneys’ Fees, Costs, and Class 26 Representative Incentive/Service Awards are hereby granted in their entirety. 27 1 Settlement Agreement, attached as Exhibit A. 2 3 3. This Court has jurisdiction over the subject matter of this litigation and 4 over all Parties to this litigation pursuant to the CAFA, including all Settlement Class 5 Members. 6 7 4. Pursuant to Federal Rules of Civil Procedure and due process, the Court 8 hereby finally approves the Settlement set for th in the Settlement Agreement, as 9 amended, and finds that such Settlement is, in all respects, fair, reasonable and 10 adequate to the Settlement Class and to each Settlement Class Member, that the 11 Settlement is ordered finally approved, and that all terms and provisions of the 12 Settlement should be and hereby are ordered to be consummated. The Court further 13 finds that the Settlement Agreement, as amended, and the Settlement set forth therein 14 were entered into in good faith following arms-length negotiations and is non- 15 collusive, and that the Settlement Classes as defined in the Settlement Agreement be 16 certified for settlement purpose s only pursuant to Fed. R. Civ. P. 23(b)(3). 17 18 5. The Court further finds that the Parties have conducted extensive and 19 costly investigation and research and counsel for the Parties are able to reasonably 20 evaluate their respective positions. The Court also finds that settlement at this time 21 will avoid additional substantial costs, as well as avoid the delay and risks that would 22 be presented by the further prosecution of this case. The Court has noted the 23 significant benefits to the Settlement Class Members under the Settlement. The 24 Court also finds that the Settlement Classes (defined in the Settlement Agreement 25 and below) are properly certified for settlement purposes only under Fed. R. Civ. P. 26 23(b)(3) and are therefore finally certified for settlement purposes only. 27 1 enforced according to its terms. 2 3 7. For purposes of this Judgment, the following Settlement Classes will be 4 certified (collectively referred to as the “Settlement Class”): 5 a. Pharmacist Settlement Class: All hourly, non-exempt retail 6 pharmacists who worked in Regions 65 or 72 in California between July 20, 2012 and 7 the date of the Preliminary Approval Order, whose claims are not subject to arbitration 8 and who have not previously released and/or adjudicated the Released Claims, and 9 whose LEARNet and/or Site Minder data indicates activity when time punch records do 10 not show he or she was clocked-in; and 11 b. Retail Pharmacy Settlement Class: Any person who is not a member 12 of the Pharmacist Settlement Class who held an hourly, non-exempt position in a CVS 13 retail pharmacy in the State of California between August 3, 2014 and the date of the 14 Preliminary Approval Order who has not previously released and/or adjudicated the 15 Released Claims. 16 17 8. The following Settlement Class Members have validly opted-out of this 18 action and are thus not bound by the Rule 23 settlement: SIMID FirstName LastName 19 5748 Neil Patel 20 6269 Felicia Ivy 6315 Daisy Tavares 21 13684 Kazim Cevik 22 14595 Yousef Trabouly 23 19651 Pauline Mikhail 12570 Marlcos Abayhon 24 19341 Mehrnaz Akhavan 25 8294 Isabel Alexander 4173 Behnam Amir-Behboudi 26 6538 Samantha Andrews 27 15149 Jaweed Assar 20088 Marisol Baez 1 17671 Kristina Bailey 13016 Johni Ballout 2 11486 Brianna Bertrand 272 Carmen Blanco 3 16870 Dayna Bowles 4 7181 Anne Cabrera 5 2340 Abel Cachola 8946 Deisy Campbell 6 2352 Heather Cano 7 828 Celia Carlton 5157 Steven Chalker 8 9424 Maisha Cherry 9 2267 Robyn Corry 16088 Margee Mae Dela Cruz 10 9972 Jose Delgado 11 17656 Hardeep Dhillon 19069 Michelle Dias 12 10940 Meredieth Dorado 13 18907 Regine Angela Duhon 14 2871 Lamise Elsayed 2026 Masoumeh Esfandiari 15 16671 Consuelo Estrada- Rodriguez 16 17291 Mary Fatouh Albana 17259 Brittany Francisco 17 10054 Diane Gailey 18 7533 Candice Gamez 13048 Elizabeth Gardner 19 12988 Beshoy Gerges 20 2794 Randall Gibbs 13626 Devonna Gilmore 21 153 Rachel Goff 22 8421 Roxanna Gonzalez 23 1447 Mehrnaz Hakimi 3166 Stephanie Han 24 4997 Tatiana Hartz 25 18078 Jasmine Hashemieh-Estes 17146 Deborah Haycox 26 3253 Lisa Helgerson 27 10376 Joanna Hernandez 17789 Maribel Hernandez 1 16630 Kaitlyn Holdren 5596 Heng Hsu 2 22165 Ryan Hyams 2439 Mahran Izoli 3 23025 Nikkolae Jacinto 4 23411 Melanie Jipp 5 16937 Jeanny Keota 8450 Harleen Khaira 6 9308 Myoungja Kim 7 23150 Diane Kim 20697 Tiffany King 8 8620 Philip Kitchen 9 4404 Amaris Lane 19661 Shaina Larmore 10 18278 Lyna Le 11 13859 Michelle Masshar 2924 Kelly Matsuura 12 13251 Nora Meincke 13 8236 Kyrollos Mekail 14 18263 Shirin Moghtanei 19186 Patricia Moore 15 5123 Betty Nabizadeh 16 18384 Maikel Nagib 22403 Trent Nelson 17 12127 Nikkie Nguyen 18 1718 Marlon Ordenana 19930 Shivjot Pabla 19 13117 Elisha Pennington 20 23700 Silva Petrosyan 3275 Lieu Pham 21 23101 Sarah Pollard 22 19579 Steve Quan 23 24118 Aryan Rabbani 23179 Randall Radtke 24 23811 Mariam Rafiqi 2

Free access — add to your briefcase to read the full text and ask questions with AI

Sevag Chalian v. CVS Pharmacy, Inc, (C.D. Cal. 2021).

Sevag Chalian v. CVS Pharmacy, Inc (Sevag Chalian v. CVS Pharmacy, Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related